DJ Amgen Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Amgen Inc. $(AMGN)$ slipped 1.30% to $292.62 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.01% to 6,449.15 and Dow Jones Industrial Average falling 0.08% to 44,911.82.
The stock's fall snapped a three-day winning streak.
Amgen Inc. closed 13.72% short of its 52-week high of $339.17, which the company achieved on September 23rd.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 0.22% to $176.25, Pfizer Inc. $(PFE)$ fell 0.28% to $25.07, and AbbVie Inc. $(ABBV)$ fell 0.06% to $206.57.
Trading volume (1.7 M) remained 624,984 below its 50-day average volume of 2.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 18, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
August 18, 2025 16:35 ET (20:35 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.